Common Contracts
4 similar Indemnification Agreement contracts by Cempra, Inc., Cempra Holdings, LLC
AMENDED AND RESTATED INDEMNIFICATION AGREEMENTIndemnification Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2017 by and among, Melinta Therapeutics, Inc., f/k/a Cempra, Inc., a Delaware corporation, Cempra Pharmaceuticals, Inc., a Delaware corporation, CEM-102 Pharmaceuticals, Inc., a Delaware corporation, and Melinta Subsidiary Corp., f/k/a Melinta Therapeutics, Inc., a Delaware corporation (each an “Indemnitor” and collectively, the “Indemnitors”), and (“Indemnitee”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2017 by and among, Melinta Therapeutics, Inc., f/k/a Cempra, Inc., a Delaware corporation, Cempra Pharmaceuticals, Inc., a Delaware corporation, CEM-102 Pharmaceuticals, Inc., a Delaware corporation, and Melinta Subsidiary Corp., f/k/a Melinta Therapeutics, Inc., a Delaware corporation (each an “Indemnitor” and collectively, the “Indemnitors”), and (“Indemnitee”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 3rd, 2017 • Cempra, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 2017 by and among, Melinta Therapeutics, Inc., f/k/a Cempra, Inc., a Delaware corporation, Cempra Pharmaceuticals, Inc., a Delaware corporation, CEM-102 Pharmaceuticals, Inc., a Delaware corporation, and Melinta Subsidiary Corp., f/k/a Melinta Therapeutics, Inc., a Delaware corporation (each an “Indemnitor” and collectively, the “Indemnitors”), and (“Indemnitee”).
INDEMNIFICATION AGREEMENTIndemnification Agreement • October 12th, 2011 • Cempra Holdings, LLC • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of , 201 by and among, Cempra Pharmaceuticals, Inc., a Delaware corporation, CEM-102 Pharmaceuticals, Inc. a Delaware corporation, and Cempra, Inc., a Delaware corporation (each an “Indemnitor” and collectively, the “Indemnitors”) and , a resident of the State of (“Indemnitee”).
